Opportunity Information: Apply for HRSA 16 174
Apply for HRSA 16 174
- The HHS-HRSA in the health sector is offering a public funding opportunity titled "International AIDS Education and Training Center" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.266.
- This funding opportunity was created on Mar 23, 2016 and posted on Mar 23, 2016.
- Applicants must submit their applications by May 23, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The International AIDS Education and Training Center (IAETC) grant opportunity (HRSA-16-174) is a Health Resources and Services Administration (HRSA) cooperative agreement designed to strengthen the global HIV response by building a capable, well-distributed health workforce and improving the systems that support HIV prevention and treatment. The program is explicitly aligned with PEPFAR 3.0 priorities and the UNAIDS 90-90-90 targets, with a strong emphasis on measurable impact, routine use of data, long-term sustainability, and accountability. In practical terms, IAETC funding is meant to help countries move closer to HIV epidemic control by improving performance across the full HIV treatment cascade, from diagnosis and linkage to care through retention on treatment and viral suppression.
At its core, IAETC focuses on improving health outcomes for people living with HIV by strengthening health systems and workforce capacity in regions with significant or rising HIV and other infectious disease burdens, including sub-Saharan Africa, the Caribbean, Central Asia, Eastern Europe, and Latin America. The program expects recipients to do more than deliver one-off trainings; it prioritizes approaches that are tested, evaluated, refined, and then scaled. The main objectives include identifying and expanding effective and efficient HIV service delivery models through technical assistance, consultation, and training; strengthening evidence-based, comprehensive prevention approaches with particular attention to key populations and to adolescent girls and young women; and improving critical cascade outcomes such as diagnosis, linkage, treatment initiation, retention, and viral suppression.
A major focus area is practice transformation, which is framed as a structured process for helping providers and clinics redesign how care is delivered so it is more integrated, efficient, and consistently high quality. This includes change management and leadership engagement, using quality improvement methods, and adopting clinic operations that support continuity of care, such as empanelment (linking patients to specific providers or teams). It also promotes team-based care and cross-training so staff can cover complementary roles, organized and evidence-based care supported by decision tools, and patient-centered approaches that increase patient involvement in their own care. Programs are also expected to improve access (including after-hours access to clinical information where feasible) and strengthen care coordination to reduce duplicated services and unnecessary costs. A notable requirement within this area is the use of human resources for health (HRH) data to better target interventions and optimize staffing models in ways that directly improve outcomes.
Another key priority is expanding access to prevention and care for key populations and for adolescent girls and young women, recognizing that epidemic control depends on reaching people at highest risk and addressing the social and structural barriers that keep them from services. IAETC supports capacity development for service delivery models tailored to these groups, including adapting HRSA evidence-based models used domestically and internationally, and using mentoring approaches in clinical settings. The opportunity also calls for strategies to reduce stigma and discrimination in low-resource contexts and encourages pilots that offer pre-exposure prophylaxis (PrEP) to populations at elevated risk of acquiring HIV, with an expectation that successful pilots will be evaluated and scaled when appropriate.
The program also places heavy emphasis on using data to drive disease control efforts. Recipients may develop or refine health information systems to better integrate HIV clinical care data with surveillance and laboratory data, improving the ability to track patient outcomes and program performance. A central concept here is "data to care," which uses surveillance or related data to identify people diagnosed with HIV who are not currently in care, link them to services, or re-engage them if they have fallen out of treatment. This involves not only technical system improvements but also capacity building so local teams can implement surveillance-informed outreach and strengthen engagement and antiretroviral therapy use along the treatment continuum.
IAETC is also intended to strengthen both pre-service and in-service education for the health workforce. This includes improving academic programs and continuing education structures for clinicians, allied health professionals, and other staff involved in preventing, diagnosing, and treating HIV and managing associated communicable and non-communicable comorbidities. The opportunity highlights the importance of collaboration among Ministries of Health and Education, along with professional councils and regulatory bodies, so workforce development efforts align with national plans and contribute to broader HRH strategy. In addition, recipients are expected to support policy, legislation, and regulatory improvements that enable health system strengthening, including reforms to curricula and training systems, faculty development, continuing professional development, retention strategies, and leadership development, all oriented toward institutionalizing improvements rather than relying on temporary project-based gains.
Interprofessional practice is another explicit requirement. The program treats interprofessional education and team-based clinical mentoring as foundational to high-quality and safe HIV care, and encourages partnerships that bring together medicine, nursing, dentistry, public health, pharmacy, behavioral health, allied health, and other relevant cadres. This includes improving curricula to reflect interprofessional competencies and reinforcing those competencies through mentored practice, with the expectation that better-functioning teams will translate into more efficient care delivery and better patient outcomes.
Because this is a cooperative agreement, recipients should expect substantial federal involvement in oversight and performance expectations. The opportunity requires strong monitoring, evaluation, and reporting aligned with PEPFAR Monitoring, Evaluation, and Reporting (MER) standards and strategic information guidance from the Office of the U.S. Global AIDS Coordinator (OGAC). Recipients must also comply with the Site Improvement through Monitoring System (SIMS), meaning U.S. Government site visits and verification activities are part of the accountability structure, and awardees must provide HRSA (or its designee) reasonable access to sites, documents, personnel, and relevant data, including by flowing these access provisions down to subawards and contracts. Finally, any PEPFAR-funded activities must follow PEPFAR branding guidance, including logo use and attribution rules.
Administratively, the opportunity is listed as a discretionary funding program under CFDA 93.266 and was issued by HHS HRSA, with an original and current closing date of May 23, 2016. The funding instrument is a cooperative agreement, and the announcement anticipated making two awards. The listed award ceiling is shown as 0 in the source data, which typically indicates the ceiling was not specified in that field rather than implying no funding; applicants generally would confirm budget limits and expectations in the full notice and related HRSA guidance. Eligibility is described broadly as "Others" with clarification in the full eligibility text, suggesting applicants needed to consult the complete announcement for the precise list of eligible organization types and any partnership requirements.
FAQs: International AIDS Education and Training Center (IAETC) Grant Opportunity (HRSA-16-174)
What is the IAETC grant opportunity (HRSA-16-174)?
The International AIDS Education and Training Center (IAETC) grant opportunity (HRSA-16-174) is a Health Resources and Services Administration (HRSA) cooperative agreement focused on strengthening the global HIV response by building a capable, well-distributed health workforce and improving the systems that support HIV prevention and treatment.
What is the main purpose of IAETC funding?
IAETC funding is intended to help countries move closer to HIV epidemic control by improving performance across the full HIV treatment cascade, including diagnosis, linkage to care, retention on treatment, and viral suppression. The program emphasizes measurable impact, routine use of data, long-term sustainability, and accountability.
Which global priorities and targets does the program align with?
The IAETC program is explicitly aligned with PEPFAR 3.0 priorities and the UNAIDS 90-90-90 targets, with a strong focus on results and data-driven implementation.
Which regions are emphasized under this opportunity?
The opportunity focuses on strengthening health systems and workforce capacity in regions with significant or rising HIV and other infectious disease burdens, including sub-Saharan Africa, the Caribbean, Central Asia, Eastern Europe, and Latin America.
Does IAETC focus only on delivering trainings?
No. IAETC prioritizes approaches that go beyond one-off trainings. The program emphasizes interventions that are tested, evaluated, refined, and then scaled, with the goal of sustained improvements in service delivery and outcomes.
What kinds of activities does IAETC support to improve HIV service delivery?
IAETC supports identifying and expanding effective and efficient HIV service delivery models through technical assistance, consultation, and training, with an emphasis on improving key cascade outcomes such as diagnosis, linkage, treatment initiation, retention, and viral suppression.
What is “practice transformation” in the IAETC context?
Practice transformation is described as a structured process that helps providers and clinics redesign how care is delivered so it becomes more integrated, efficient, and consistently high quality. It includes leadership engagement, change management, quality improvement methods, and improved clinic operations that support continuity of care.
What specific clinic or workflow changes are encouraged under practice transformation?
The opportunity highlights strategies such as empanelment (linking patients to specific providers or teams), team-based care and cross-training, evidence-based care supported by decision tools, patient-centered approaches to increase patient involvement, improvements in access (including after-hours access to clinical information where feasible), and stronger care coordination to reduce duplicated services and unnecessary costs.
Is the use of human resources for health (HRH) data required or expected?
Within the practice transformation focus area, the opportunity includes a notable requirement to use human resources for health (HRH) data to better target interventions and optimize staffing models in ways that directly improve outcomes.
How does IAETC address prevention and care for key populations and adolescent girls and young women?
IAETC prioritizes expanding access to prevention and care for key populations and for adolescent girls and young women. It supports capacity development for tailored service delivery models and recognizes the need to address social and structural barriers that prevent people at highest risk from accessing services.
Does the opportunity include efforts to reduce stigma and discrimination?
Yes. The opportunity calls for strategies to reduce stigma and discrimination in low-resource contexts as part of improving access to prevention and care, especially for populations most affected by these barriers.
Does IAETC support PrEP activities?
The opportunity encourages pilots that offer pre-exposure prophylaxis (PrEP) to populations at elevated risk of acquiring HIV, with an expectation that successful pilots will be evaluated and scaled when appropriate.
What does “data to care” mean in this program?
“Data to care” is described as using surveillance or related data to identify people diagnosed with HIV who are not currently in care and to link them to services or re-engage them if they have fallen out of treatment. This includes both technical improvements and capacity building so local teams can implement surveillance-informed outreach and strengthen engagement and antiretroviral therapy use along the treatment continuum.
What kinds of data system improvements may be supported?
Recipients may develop or refine health information systems to better integrate HIV clinical care data with surveillance and laboratory data. The goal is to improve the ability to track patient outcomes and program performance.
How does the opportunity address pre-service and in-service health workforce education?
IAETC is intended to strengthen both pre-service and in-service education by improving academic programs and continuing education structures for clinicians, allied health professionals, and other staff involved in preventing, diagnosing, and treating HIV and managing related comorbidities.
Are partnerships with government and professional bodies emphasized?
Yes. The opportunity highlights collaboration among Ministries of Health and Education as well as professional councils and regulatory bodies so workforce development aligns with national plans and contributes to broader human resources for health strategies.
Does IAETC include policy, legislative, or regulatory work?
Yes. Recipients are expected to support policy, legislation, and regulatory improvements that enable health system strengthening, including reforms to curricula and training systems, faculty development, continuing professional development, retention strategies, and leadership development aimed at institutionalizing improvements.
What is required regarding interprofessional practice?
Interprofessional practice is an explicit requirement. The program treats interprofessional education and team-based clinical mentoring as foundational to high-quality and safe HIV care and encourages partnerships across disciplines such as medicine, nursing, dentistry, public health, pharmacy, behavioral health, allied health, and other relevant cadres.
How does the cooperative agreement structure affect recipients?
Because this funding instrument is a cooperative agreement, recipients should expect substantial federal involvement in oversight and performance expectations.
What monitoring, evaluation, and reporting standards apply?
The opportunity requires strong monitoring, evaluation, and reporting aligned with PEPFAR Monitoring, Evaluation, and Reporting (MER) standards and strategic information guidance from the Office of the U.S. Global AIDS Coordinator (OGAC).
What is SIMS and how does it affect awardees?
The program requires compliance with the Site Improvement through Monitoring System (SIMS). This means U.S. Government site visits and verification activities are part of the accountability structure.
What access must awardees provide to HRSA or its designee?
Awardees must provide HRSA (or its designee) reasonable access to sites, documents, personnel, and relevant data. The opportunity also indicates these access provisions must be flowed down to subawards and contracts.
Are there branding requirements for PEPFAR-funded activities?
Yes. Any PEPFAR-funded activities must follow PEPFAR branding guidance, including logo use and attribution rules.
Which agency issues this opportunity and what is the CFDA number?
The opportunity was issued by the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) and is listed as a discretionary funding program under CFDA 93.266.
What is the funding instrument type?
The funding instrument is a cooperative agreement.
What was the closing date listed for this opportunity?
The original and current closing date listed is May 23, 2016.
How many awards were anticipated?
The announcement anticipated making two awards.
What does it mean that the award ceiling is shown as 0?
The source data shows an award ceiling of 0, which typically indicates the ceiling was not specified in that field rather than implying there is no funding. The details would normally be confirmed in the full notice and related HRSA guidance.
Who is eligible to apply?
Eligibility is described broadly as "Others" with clarification in the full eligibility text. This suggests applicants would need to consult the complete announcement for the precise list of eligible organization types and any partnership requirements.
Browse more business programs for Training Services
Browse more opportunities from the same agency: HHS-HRSA
Browse more opportunities from the same category: Health
Next opportunity: Maine Conservation Innovation Grant
Previous opportunity: Maternal and Child Health Measurement Research Network
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 16 174
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 16 174) also looked into and applied for these:
| Funding Opportunity |
|---|
| Health Communication and Marketing (HCM) Kenya Apply for RFA 615 16 000002 Funding Number: RFA 615 16 000002 Agency: USAID-KEN Category: Health Funding Amount: $42,500,000 |
| Economic Modeling for HIV, Viral Hepatitis, Sexually Transmitted Diseases, Tuberculosis and School Health Apply for CDC RFA PS14 141503CONT16 Funding Number: CDC RFA PS14 141503CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01) Apply for PAR 16 150 Funding Number: PAR 16 150 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Office of Tribal Self-Governance Planning Cooperative Agreement Apply for HHS 2016 IHS TSGP 0001 Funding Number: HHS 2016 IHS TSGP 0001 Agency: HHS-IHS Category: Health Funding Amount: $120,000 |
| Office of Tribal Self-Governance Negotiation Cooperative Agreement Apply for HHS 2016 IHS TSGN 0001 Funding Number: HHS 2016 IHS TSGN 0001 Agency: HHS-IHS Category: Health Funding Amount: $48,000 |
| Prescription Drug Overdose: Data-Driven Prevention Initiative (DDPI) Apply for CDC RFA CE16 1606 Funding Number: CDC RFA CE16 1606 Agency: HHS-CDC-NCIPC Category: Health Funding Amount: $750,000 |
| PPHF 2016: Immunization Grants - Increasing IIS Sentinel Site Capacity for Enhanced Program Support – Financed in part by 2016 Prevention and Public Health Funds Apply for CDC RFA IP14 140703CONTPPHF16 Funding Number: CDC RFA IP14 140703CONTPPHF16 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: Case Dependent |
| PPHF 2016: Epidemiology and Laboratory Capacity Program – Emerging Infections Programs – Financed in part by 2016 Prevention and Public Health Funds Apply for CDC RFA CK12 120905CONTPPHF16 Funding Number: CDC RFA CK12 120905CONTPPHF16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Collecting Violent Death Information Using the National Violent Death Reporting System (NVDRS) Apply for CDC RFA CE16 1607 Funding Number: CDC RFA CE16 1607 Agency: HHS-CDC-NCIPC Category: Health Funding Amount: $878,000 |
| Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R01) Apply for PAR 16 154 Funding Number: PAR 16 154 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R21) Apply for PAR 16 153 Funding Number: PAR 16 153 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| NeuroNEXT Clinical Trials (U01) Apply for PAR 16 155 Funding Number: PAR 16 155 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Newborn Screening Implementation Program Regarding Conditions Added to the Recommended Uniform Screening Panel (RUSP) Apply for HRSA 16 062 Funding Number: HRSA 16 062 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Use of Imaging and Digital Image Analysis Software/s to Evaluate Transdermal Irritation and Non - inferiority of Generic Transdermal Products (U01) Apply for RFA FD 16 010 Funding Number: RFA FD 16 010 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Generic Drug Substitution in Special Populations (U01) Apply for RFA FD 16 011 Funding Number: RFA FD 16 011 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Adult Maturational Changes and Dysfunctions in Emotion Regulation (R01) Apply for RFA MH 17 405 Funding Number: RFA MH 17 405 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Preventing Teen Dating and Youth Violence by Addressing Shared Risk and Protective Factors Apply for CDC RFA CE16 1605 Funding Number: CDC RFA CE16 1605 Agency: HHS-CDC-NCIPC Category: Health Funding Amount: $412,500 |
| TRANSFORM/Primary Health Care Unit (PHCU) Apply for APS 663 16 000005 Funding Number: APS 663 16 000005 Agency: USAID-ETH Category: Health Funding Amount: $120,000,000 |
| NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) Apply for PAR 16 156 Funding Number: PAR 16 156 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) grants Apply for TI 16 014 Funding Number: TI 16 014 Agency: HHS-SAMHS Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 16 174", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.